Meet our 2022 Annual Conference Co-Chairs
Jesper Andersen, PhD
Andersen Group
Biotech Research and Innovation Centre (BRIC)
Department of Health and Medical Sciences
University of Copenhagen
Copenhagen, Denmark
Lipika Goyal, MD, MPhil
Lead of the Liver Cancer Research Program
Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, USA
COVID-19 PRECAUTIONS & REQUIREMENTS
We are closely following the latest COVID-19 developments, particularly the increased caseloads from the Omicron variant. We will be following the State of Utah and City of Salt Lake guidelines and mandates regarding in-person events. We will be holding an in-person conference (with Hybrid options) unless an in-person event is prohibited by Local, State, or Federal mandates.
To help manage the safety of all, attendees must be fully vaccinated for COVID-19 and be masked. We are adhering to local safety guidelines and regulations.
If you are unable to join us in person, we welcome and encourage you to attend the conference virtually. Regardless of how you attend, register now.
2022 Annual Conference FAQs
2021 Conference by the Numbers
Who Should Attend?
Who Should Attend?
- Researchers
- Physicians
- Oncologists
- Radiologists
- Surgeons
- Gastroenterologists
- Hepatologists
- Nurses specializing in oncology, intensive care, and palliative care
- Pharmaceutical Companies
- Government Regulators
- Policymakers
- Patients, Caregivers and others invested in the field of cholangiocarcinoma